Analysis of Cranex Limited (CRANEX)
Cranex Limited has been showing some volatility in its stock price over the past few days. The Relative Strength Index (RSI) values have been fluctuating around the 50 level, indicating a balanced market sentiment between buying and selling pressure.
The Moving Average Convergence Divergence (MACD) indicator has been negative, suggesting a bearish trend in the stock price. The MACD histogram has been consistently below the zero line, indicating a strong bearish momentum.
The Simple Moving Average (SMA) and Exponential Moving Average (EMA) have been relatively close to each other, but both below the current stock price, indicating a bearish trend.
Overall, based on the RSI, MACD, and moving averages, Cranex Limited seems to be in a bearish phase with downward momentum. Traders and investors may want to exercise caution and consider waiting for a more stable trend before making any trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provides a comprehensive overview of the financial and stock-related metrics for a specific company. Here are the key points:
1. **Financials**:
- **Cash Flow**: Operating cash flow for the trailing twelve months (TTM) is $110,563,000,320. Levered free cash flow TTM is $84,726,874,112.
- **Balance Sheet**: Total cash on a quarterly basis is $67,150,000,128. Total debt on a quarterly basis is $104,590,000,128. Current ratio is 1.037. Book value per share is $4.837. Total cash per share is $4.379. Total debt to equity ratio is 140.968.
- **Profit Margin**: The profit margin is 26.306%.
- **Income Statement**: EBITDA is $131,393,000,000. Revenue TTM is $381,623,009,280. Diluted EPS TTM is $6.43. Gross profit TTM is $169,148,000,000. Revenue per share TTM is $24.537. Net income to common TTM is $100,389,003,264. Quarterly revenue growth is -4.3%. Quarterly earnings growth year-over-year is -2.2%.
- **Operating Margin**: The operating margin is 30.743%.
- **Return on Assets**: Return on assets TTM is 22.073999%.
- **Return on Equity**: Return on equity TTM is 147.25%.
2. **Stock Statistics**:
- Short ratio is 1.53.
- Float shares are 15,308,320,742.
- Shares short are 99,287,450.
- Average 10-day volume is 46,860,048.
- Average 90-day volume is 57,498,254.
- Shares outstanding are 15,334,099,968.
- Percent held by insiders is 5.22%.
- Percent held by institutions is 57.589%.
- Short percent of shares outstanding is 0.65%.
3. **Valuations Metrics**:
- PEG ratio is 26.319502.
- Forward PE ratio is 26.319502.
- Trailing PE ratio is 29.59409.
- Enterprise value is $2,950,762,332,160.
- Price to book ratio on a quarterly basis is 39.3405.
- Price to sales TTM is 7.646095.
- Enterprise to EBITDA ratio is 22.763.
- Enterprise to revenue ratio is 7.732.
- Market capitalization is $2,917,925,650,432.
4. **Stock Price Summary**:
- Beta is 1.264.
- 50-day moving average is $176.2646.
- 200-day moving average is $181.0429.
- 52-week low is $164.08.
- 52-week high is $199.62.
- 52-week change is 6.853%.
5. **Dividends and Splits**:
- Payout ratio is 14.93%.
- Dividend date is May 16, 2024.
- Last split date is August 31, 2020 (4-for-1 split).
- Ex-dividend date is May 10, 2024.
- Forward annual dividend rate is $1.
- 5-year average dividend yield is 0.73%.
- Forward annual dividend yield is 0.5255%.
- Trailing annual dividend rate is $0.97.
- Trailing annual dividend yield is 0.5097%.
Income statement 💸
These are the revenues. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The gross profit margin seems to be consistent, indicating stable pricing and cost management.
3. Operating income has also shown a positive trend, reflecting efficient operational performance.
4. Net income has been growing, suggesting effective cost control and revenue generation.
5. Earnings per share (EPS) have generally been increasing, indicating improved profitability on a per-share basis.
6. The company has been able to maintain a healthy EBITDA margin, showing strong operational efficiency.
7. Despite fluctuations in some expenses and income components, the overall financial performance seems to be on an upward trajectory.
8. The company's tax management appears to be effective, with a reasonable income tax expense relative to the income generated.
9. The number of shares outstanding has remained relatively stable, which can impact metrics like EPS and net income.
10. Overall, the financial data suggests that the company has been performing well and growing its top line consistently.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been investing more in non-current assets over the years, which might indicate long-term growth strategies.
7. The company has been relying more on equity financing rather than debt financing, as seen in the increasing shareholders' equity compared to liabilities.
8. The company's liquidity position has varied over the years, as seen in the fluctuations of current assets and liabilities.
9. Accumulated depreciation has been significant, indicating the age and wear of the company's assets.
10. The company has been managing its risks by maintaining provisions for risks and charges in its balance sheet.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
5. Investing activities include the sale and purchase of investments, capital expenditures, and other investing activities.
6. The end cash position has also been fluctuating, reaching its highest value in 2020 and its lowest in 2022.
These conclusions provide insights into the company's financial performance and management of cash flows over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is also an increase from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, showing growth trends in both the quarterly and annual performance.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate to healthy growth expected in both the short term and the long term.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still projected to be healthy.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty or differing opinions among analysts.MACD of CRANEX